Skip to main content
Top
Published in: Journal of General Internal Medicine 6/2019

01-06-2019 | Addiction | Original Research

Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization

Authors: Sarah E. Wakeman, MD, Nancy A. Rigotti, MD, Yuchiao Chang, PhD, Grace E. Herman, BA, Ann Erwin, MMHS, Susan Regan, PhD, Joshua P. Metlay, MD, PhD

Published in: Journal of General Internal Medicine | Issue 6/2019

Login to get access

Abstract

Background

Components of substance use disorder (SUD) treatment have been shown to reduce inpatient and emergency department (ED) utilization. However, integrated treatment using pharmacotherapy and recovery coaches in primary care has not been studied.

Objective

To determine whether integrated addiction treatment in primary care reduces inpatient and ED utilization and improves outpatient engagement.

Design

A retrospective cohort study comparing patients in practices with and without integrated addiction treatment including pharmacotherapy and recovery coaching during a staggered roll-out period.

Participants

A propensity score matched sample of 2706 adult primary care patients (1353 matched pairs from intervention and control practices) with a SUD diagnosis code, excluding cannabis or tobacco only, matched on baseline utilization.

Intervention

A multi-modal strategy that included forming interdisciplinary teams of local champions, access to addiction pharmacotherapy, counseling, and recovery coaching. Control practices could refer patients to an addiction treatment clinic offering pharmacotherapy and behavioral interventions.

Main Measures

The number of inpatient admissions, hospital bed days, ED visits, and primary care visits.

Key Results

During the follow-up period, there were fewer inpatient days among the intervention group (997 vs. 1096 days with a mean difference of 7.3 days per 100 patients, p = 0.03). The mean number of ED visits was lower for the intervention group (36.2 visits vs. 42.9 per 100 patients, p = 0.005). There was no difference in the mean number of hospitalizations. The mean number of primary care visits was higher for the intervention group (317 visits vs. 270 visits per 100 patients, p < 0.001). Intervention practices had a greater increase in buprenorphine and naltrexone prescribing.

Conclusions

In a non-randomized retrospective cohort study, integrated addiction pharmacotherapy and recovery coaching in primary care resulted in fewer hospital days and ED visits for patients with SUD compared to similarly matched patients receiving care in practices without these services.
Literature
1.
go back to reference Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend 2008; 97(3):226–30.CrossRefPubMedPubMedCentral Cherpitel CJ, Ye Y. Drug use and problem drinking associated with primary care and emergency room utilization in the US general population: data from the 2005 national alcohol survey. Drug Alcohol Depend 2008; 97(3):226–30.CrossRefPubMedPubMedCentral
2.
go back to reference Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, Jack BW. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med 2012; 6(1):50–6.CrossRefPubMedPubMedCentral Walley AY, Paasche-Orlow M, Lee EC, Forsythe S, Chetty VK, Mitchell S, Jack BW. Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis. J Addict Med 2012; 6(1):50–6.CrossRefPubMedPubMedCentral
4.
go back to reference Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, Schottenfeld RS. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med 2013;126(1):74.e11–7.CrossRef Fiellin DA, Barry DT, Sullivan LE, Cutter CJ, Moore BA, O'Connor PG, Schottenfeld RS. A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine. Am J Med 2013;126(1):74.e11–7.CrossRef
5.
go back to reference Liebschutz JM, Crooks D, Herman D et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med 2014;174(8):1369–76.CrossRefPubMedPubMedCentral Liebschutz JM, Crooks D, Herman D et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med 2014;174(8):1369–76.CrossRefPubMedPubMedCentral
6.
go back to reference D'Onofrio G, O'Connor PG, Pantalon MV et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA 2015;313(16):1636–44.CrossRefPubMedPubMedCentral D'Onofrio G, O'Connor PG, Pantalon MV et al. Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial. JAMA 2015;313(16):1636–44.CrossRefPubMedPubMedCentral
7.
go back to reference Walley AY, Palmisano J, Sorensen-Alawad A, Chaisson C, Raj A, Samet JH, Drainoni ML. Engagement and substance dependence in a primary care-based addiction treatment program for people infected with HIV and people at high-risk for HIV infection. J Subst Abus Treat 2015;59:59–66.CrossRef Walley AY, Palmisano J, Sorensen-Alawad A, Chaisson C, Raj A, Samet JH, Drainoni ML. Engagement and substance dependence in a primary care-based addiction treatment program for people infected with HIV and people at high-risk for HIV infection. J Subst Abus Treat 2015;59:59–66.CrossRef
8.
go back to reference Baser O, Chalk M, Fiellin DA, Gastfriend DR. Cost and utilization outcomes of opioid-dependence treatments. Am J Manag Care 2011;17 Suppl 8:S235–48.PubMed Baser O, Chalk M, Fiellin DA, Gastfriend DR. Cost and utilization outcomes of opioid-dependence treatments. Am J Manag Care 2011;17 Suppl 8:S235–48.PubMed
9.
go back to reference Bryson WC, McConnell J, Korthuis PT, McCarty D. Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. Am J Manag Care 2011;17 Suppl 8:S222–34.PubMedPubMedCentral Bryson WC, McConnell J, Korthuis PT, McCarty D. Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. Am J Manag Care 2011;17 Suppl 8:S222–34.PubMedPubMedCentral
10.
go back to reference Tkacz J, Volpicelli J, Un H, Ruetsch C. Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients. J Subst Abus Treat 2014;46(4):456–62.CrossRef Tkacz J, Volpicelli J, Un H, Ruetsch C. Relationship between buprenorphine adherence and health service utilization and costs among opioid dependent patients. J Subst Abus Treat 2014;46(4):456–62.CrossRef
11.
go back to reference Wei J, Defries T, Lozada M, Young N, Huen W, Tulsky J. An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits. J Gen Intern Med 2015;30(3):365–70.CrossRefPubMed Wei J, Defries T, Lozada M, Young N, Huen W, Tulsky J. An inpatient treatment and discharge planning protocol for alcohol dependence: efficacy in reducing 30-day readmissions and emergency department visits. J Gen Intern Med 2015;30(3):365–70.CrossRefPubMed
12.
go back to reference Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 2001;286(14):1715–23.CrossRefPubMedPubMedCentral Weisner C, Mertens J, Parthasarathy S, Moore C, Lu Y. Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA 2001;286(14):1715–23.CrossRefPubMedPubMedCentral
13.
go back to reference Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A. Peer-delivered recovery support services for addictions in the United States: a systematic review. J Subst Abus Treat 2016;63; 1–9.CrossRef Bassuk EL, Hanson J, Greene RN, Richard M, Laudet A. Peer-delivered recovery support services for addictions in the United States: a systematic review. J Subst Abus Treat 2016;63; 1–9.CrossRef
14.
go back to reference Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases Post-discharge abstinence and reduces addiction severity. J Gen Intern Med 2017;32(8):909–916.CrossRefPubMedPubMedCentral Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases Post-discharge abstinence and reduces addiction severity. J Gen Intern Med 2017;32(8):909–916.CrossRefPubMedPubMedCentral
15.
go back to reference Kendall CE, Boucher LM, Mark AE, Martin A, et al. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada. Harm Reduct J (2017) 14:16.CrossRefPubMedPubMedCentral Kendall CE, Boucher LM, Mark AE, Martin A, et al. A cohort study examining emergency department visits and hospital admissions among people who use drugs in Ottawa, Canada. Harm Reduct J (2017) 14:16.CrossRefPubMedPubMedCentral
17.
go back to reference Wakeman SE, Kanter GP, Donelan K. Institutional substance use disorder intervention improves general internist preparedness, attitudes, and clinical practice. J Addict Med 2017;11(4):308–314.CrossRefPubMed Wakeman SE, Kanter GP, Donelan K. Institutional substance use disorder intervention improves general internist preparedness, attitudes, and clinical practice. J Addict Med 2017;11(4):308–314.CrossRefPubMed
18.
go back to reference Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12(2):128–33.CrossRefPubMedPubMedCentral Hutchinson E, Catlin M, Andrilla CH, Baldwin LM, Rosenblatt RA. Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12(2):128–33.CrossRefPubMedPubMedCentral
19.
go back to reference Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abus Treat. 2017;78:1–7.CrossRef Huhn AS, Dunn KE. Why aren’t physicians prescribing more buprenorphine? J Subst Abus Treat. 2017;78:1–7.CrossRef
20.
go back to reference Hassamal S, Goldenberg M, Ishak W, Haglund M, Miotto K, Danovitch I. Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: a case report and narrative literature review. J Psychiatr Pract 2017;23(3):221–229.CrossRefPubMed Hassamal S, Goldenberg M, Ishak W, Haglund M, Miotto K, Danovitch I. Overcoming barriers to initiating medication-assisted treatment for heroin use disorder in a general medical hospital: a case report and narrative literature review. J Psychiatr Pract 2017;23(3):221–229.CrossRefPubMed
21.
go back to reference Mohlman MK, Tanzman B, Finison K, Pinette M, Jones C. Impact of medication assisted treatment for opioid addiction on Medicaid expenditures and health services utilization rates in Vermont. J Subst Abus Treat 2016;67:9–14.CrossRef Mohlman MK, Tanzman B, Finison K, Pinette M, Jones C. Impact of medication assisted treatment for opioid addiction on Medicaid expenditures and health services utilization rates in Vermont. J Subst Abus Treat 2016;67:9–14.CrossRef
22.
go back to reference Raven MC, Doran KM, Kostrowski S, Gillespie CC, Elbel BD. An intervention to improve care and reduce costs for high-risk patients with frequent hospital admissions: a pilot study. BMC Health Serv Res 2011;11:270.CrossRefPubMedPubMedCentral Raven MC, Doran KM, Kostrowski S, Gillespie CC, Elbel BD. An intervention to improve care and reduce costs for high-risk patients with frequent hospital admissions: a pilot study. BMC Health Serv Res 2011;11:270.CrossRefPubMedPubMedCentral
23.
go back to reference Haddad MS, Zelenev A, Altice FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health 2015;92(1):193–213.CrossRefPubMed Haddad MS, Zelenev A, Altice FL. Buprenorphine maintenance treatment retention improves nationally recommended preventive primary care screenings when integrated into urban federally qualified health centers. J Urban Health 2015;92(1):193–213.CrossRefPubMed
24.
go back to reference LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts Collaborative Care Model in community health centers. J Subst Abus Treat 2016;60:6–13.CrossRef LaBelle CT, Han SC, Bergeron A, Samet JH. Office-based opioid treatment with buprenorphine (OBOT-B): statewide implementation of the Massachusetts Collaborative Care Model in community health centers. J Subst Abus Treat 2016;60:6–13.CrossRef
26.
go back to reference Sadowski LS, Kee RA, VanderWeele TJ, Buchanan D. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA 2009;301(17):1771–1778.CrossRefPubMed Sadowski LS, Kee RA, VanderWeele TJ, Buchanan D. Effect of a housing and case management program on emergency department visits and hospitalizations among chronically ill homeless adults: a randomized trial. JAMA 2009;301(17):1771–1778.CrossRefPubMed
27.
go back to reference Frakt AB, Bagley Nphysicians prescribing more buprenorphine Protection or harm? Suppressing substance-use data. N Engl J Med 2015;372(20):1879–81. Frakt AB, Bagley Nphysicians prescribing more buprenorphine Protection or harm? Suppressing substance-use data. N Engl J Med 2015;372(20):1879–81.
Metadata
Title
Effect of Integrating Substance Use Disorder Treatment into Primary Care on Inpatient and Emergency Department Utilization
Authors
Sarah E. Wakeman, MD
Nancy A. Rigotti, MD
Yuchiao Chang, PhD
Grace E. Herman, BA
Ann Erwin, MMHS
Susan Regan, PhD
Joshua P. Metlay, MD, PhD
Publication date
01-06-2019
Publisher
Springer US
Published in
Journal of General Internal Medicine / Issue 6/2019
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-018-4807-x

Other articles of this Issue 6/2019

Journal of General Internal Medicine 6/2019 Go to the issue